Ensysce Biosciences (ENSC) stock forecast for 2025. Forecast tables and graphs.







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

Ensysce Biosciences (ENSC) stock forecast for 2025

Updated: March 28, 2024 (06:24)

Sector: Healthcare

The share price of Ensysce Biosciences, Inc. (ENSC) now

What analysts predict: $11.33
52-week High/Low: $7.44 / $0.721

50/200 Day Moving Average: $1.039 / $1.408

This figure corresponds to the Average Price over the previous 50/200 days. For Ensysce Biosciences stocks, the 50-day moving average is the resistance level today.

For Ensysce Biosciences stocks, the 200-day moving average is the resistance level today.

Are you interested in Ensysce Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Ensysce Biosciences stock price in 2025. How much will one Ensysce Biosciences share be worth in 2025? Is it worth taking profit / loss on ENSC stock now or waiting? What are analysts' forecasts for Ensysce Biosciences stock?

We forecast Ensysce Biosciences stock performance using neural networks based on historical data on ENSC stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Ensysce Biosciences, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Ensysce Biosciences analysts is $11.33. Today 200 Day Moving Average is the resistance level (1.408 $). 50 Day Moving Average is the resistance level (1.039 $).




Historical and forecast chart of Ensysce Biosciences, Inc. stock

The chart below shows the historical price of Ensysce Biosciences stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ENSC stock price can be found in the table below.


Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on proprietary technology platforms to develop safer prescription drugs. The firm’s Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms, are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company is headquartered in La Jolla, CA.

Ensysce Biosciences (ENSC) Forecast for 2025

Month Target Pes. Opt. Vol., %
Jan 1.45 1.13 1.61 29.89 %
Feb 1.37 1.17 1.46 19.76 %
Mar 1.51 1.36 1.72 21.09 %
Apr 1.67 1.49 2.02 26.10 %
May 1.61 1.43 1.76 18.61 %
Jun 1.73 1.32 2.12 37.96 %
Jul 2.04 1.62 2.37 31.76 %
Aug 2.41 2.00 2.68 25.38 %
Sep 2.39 2.00 2.66 24.84 %
Oct 2.35 1.96 2.74 28.58 %
Nov 2.00 1.66 2.45 32.49 %
Dec 1.56 1.33 1.86 28.69 %

Ensysce Biosciences information and performance

Ensysce Biosciences Address

250 WEST 57TH ST., SUITE 415, NEW YORK, NY, US

Market Capitalization: 5 973 300 $

Market capitalization of the Ensysce Biosciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ENSC shares in the company outstanding by the market price of one share.

EBITDA: -24 221 944 $

EBITDA of Ensysce Biosciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -4.69

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.641
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.558

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 7329200

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Ensysce Biosciences price target for 2025 by month


Target values for the price of one Ensysce Biosciences share for Jan 2025.

The weighted average target price per Ensysce Biosciences share in Jan 2025 is: 1.45.
In Jan, the Positive dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 29.892% volatility is expected.
Pessimistic target level: 1.13
Optimistic target level: 1.61

Target values for the price of one Ensysce Biosciences share for Feb 2025.

The weighted average target price per Ensysce Biosciences share in Feb 2025 is: 1.37.
In Feb, the Negative dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 19.756% volatility is expected.
Pessimistic target level: 1.17
Optimistic target level: 1.46

Target values for the price of one Ensysce Biosciences share for Mar 2025.

The weighted average target price per Ensysce Biosciences share in Mar 2025 is: 1.51.
In Mar, the Positive dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 21.090% volatility is expected.
Pessimistic target level: 1.36
Optimistic target level: 1.72

Target values for the price of one Ensysce Biosciences share for Apr 2025.

The weighted average target price per Ensysce Biosciences share in Apr 2025 is: 1.67.
In Apr, the Positive dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 26.098% volatility is expected.
Pessimistic target level: 1.49
Optimistic target level: 2.02

Target values for the price of one Ensysce Biosciences share for May 2025.

The weighted average target price per Ensysce Biosciences share in May 2025 is: 1.61.
In May, the Negative dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 18.613% volatility is expected.
Pessimistic target level: 1.43
Optimistic target level: 1.76

Target values for the price of one Ensysce Biosciences share for Jun 2025.

The weighted average target price per Ensysce Biosciences share in Jun 2025 is: 1.73.
In Jun, the Positive dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 37.959% volatility is expected.
Pessimistic target level: 1.32
Optimistic target level: 2.12

Target values for the price of one Ensysce Biosciences share for Jul 2025.

The weighted average target price per Ensysce Biosciences share in Jul 2025 is: 2.04.
In Jul, the Positive dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 31.756% volatility is expected.
Pessimistic target level: 1.62
Optimistic target level: 2.37

Target values for the price of one Ensysce Biosciences share for Aug 2025.

The weighted average target price per Ensysce Biosciences share in Aug 2025 is: 2.41.
In Aug, the Positive dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 25.383% volatility is expected.
Pessimistic target level: 2.00
Optimistic target level: 2.68

Target values for the price of one Ensysce Biosciences share for Sep 2025.

The weighted average target price per Ensysce Biosciences share in Sep 2025 is: 2.39.
In Sep, the Negative dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 24.843% volatility is expected.
Pessimistic target level: 2.00
Optimistic target level: 2.66

Target values for the price of one Ensysce Biosciences share for Oct 2025.

The weighted average target price per Ensysce Biosciences share in Oct 2025 is: 2.35.
In Oct, the Negative dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 28.584% volatility is expected.
Pessimistic target level: 1.96
Optimistic target level: 2.74

Target values for the price of one Ensysce Biosciences share for Nov 2025.

The weighted average target price per Ensysce Biosciences share in Nov 2025 is: 2.00.
In Nov, the Negative dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 32.492% volatility is expected.
Pessimistic target level: 1.66
Optimistic target level: 2.45

Target values for the price of one Ensysce Biosciences share for Dec 2025.

The weighted average target price per Ensysce Biosciences share in Dec 2025 is: 1.56.
In Dec, the Negative dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 28.692% volatility is expected.
Pessimistic target level: 1.33
Optimistic target level: 1.86



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.